Arotinolol (INN marketed under the tradename Almarl) is a medication in the class of mixed alpha/beta blockers. A 1979 publication suggests arotinolol as having first been described in the scientific literature by Sumitomo Chemical as β-adrenergic blocking antiarrhythmic compound S-596.
This page contains content from the copyrighted Wikipedia article "Arotinolol"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.